187 related articles for article (PubMed ID: 31293204)
21. Diagnostic values of MMP-7, MMP-9, MMP-11, TIMP-1, TIMP-2, CEA, and CA19-9 in patients with colorectal cancer.
Huang X; Lan Y; Li E; Li J; Deng Q; Deng X
J Int Med Res; 2021 May; 49(5):3000605211012570. PubMed ID: 33942633
[TBL] [Abstract][Full Text] [Related]
22. Enhanced expression of tissue inhibitors of metalloproteinases in human colorectal tumors.
Murashige M; Miyahara M; Shiraishi N; Saito T; Kohno K; Kobayashi M
Jpn J Clin Oncol; 1996 Oct; 26(5):303-9. PubMed ID: 8895669
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical expression of Notch1, Jagged1, NF-κB and MMP-9 in colorectal cancer patients and the relationship to clinicopathological parameters.
Zheng CG; Chen R; Xie JB; Liu CB; Jin Z; Jin C
Cancer Biomark; 2015; 15(6):889-97. PubMed ID: 26406415
[TBL] [Abstract][Full Text] [Related]
24. Serum levels and tissue expression of matrix metalloproteinase 2 (MMP-2) and tissue inhibitor of metalloproteinases 2 (TIMP-2) in colorectal cancer patients.
Groblewska M; Mroczko B; Gryko M; Pryczynicz A; Guzińska-Ustymowicz K; Kędra B; Kemona A; Szmitkowski M
Tumour Biol; 2014 Apr; 35(4):3793-802. PubMed ID: 24395652
[TBL] [Abstract][Full Text] [Related]
25. The suppressive role of HYAL1 and HYAL2 in the metastasis of colorectal cancer.
Jin Z; Zhang G; Liu Y; He Y; Yang C; Du Y; Gao F
J Gastroenterol Hepatol; 2019 Oct; 34(10):1766-1776. PubMed ID: 30972813
[TBL] [Abstract][Full Text] [Related]
26. Matrix metalloproteinase-9,-3 and tissue inhibitor of matrix metalloproteinase-1 in colorectal cancer: relationship to clinicopathological variables.
Işlekel H; Oktay G; Terzi C; Canda AE; Füzün M; Küpelioğlu A
Cell Biochem Funct; 2007; 25(4):433-41. PubMed ID: 16615041
[TBL] [Abstract][Full Text] [Related]
27. Increased expression of MMP-2 and MMP-9 indicates poor prognosis in glioma recurrence.
Zhou W; Yu X; Sun S; Zhang X; Yang W; Zhang J; Zhang X; Jiang Z
Biomed Pharmacother; 2019 Oct; 118():109369. PubMed ID: 31545229
[TBL] [Abstract][Full Text] [Related]
28. Serum MMP-8 and TIMP-1 predict prognosis in colorectal cancer.
Böckelman C; Beilmann-Lehtonen I; Kaprio T; Koskensalo S; Tervahartiala T; Mustonen H; Stenman UH; Sorsa T; Haglund C
BMC Cancer; 2018 Jun; 18(1):679. PubMed ID: 29929486
[TBL] [Abstract][Full Text] [Related]
29. Expression of matrix metalloproteinase-2 and its tissue inhibitor-2 in fetal and neoplastic thyroid tissue and their significance as diagnostic and prognostic markers in papillary carcinoma.
Marečko I; Cvejić D; Tatić S; Dragutinović V; Paunović I; Savin S
Cancer Biomark; 2011-2012; 11(1):49-58. PubMed ID: 22820140
[TBL] [Abstract][Full Text] [Related]
30. ING4 suppresses tumor angiogenesis and functions as a prognostic marker in human colorectal cancer.
Chen Y; Huang Y; Hou P; Zhang Z; Zhang Y; Wang W; Sun G; Xu L; Zhou J; Bai J; Zheng J
Oncotarget; 2016 Nov; 7(48):79017-79031. PubMed ID: 27806345
[TBL] [Abstract][Full Text] [Related]
31. [Expression and significance of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase in non-melanoma skin cancer].
Fu XR; Zhang C; Chen CY; Zhang L; Wang LX; Wang BH; Liu XY; Zhang MZ
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):369-73. PubMed ID: 22883459
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of MMP-2, -9 and TIMP-1,-2 immunoreactive protein at the invasive front in advanced head and neck squamous cell carcinomas.
Ondruschka C; Buhtz P; Motsch C; Freigang B; Schneider-Stock R; Roessner A; Boltze C
Pathol Res Pract; 2002; 198(8):509-15. PubMed ID: 12389993
[TBL] [Abstract][Full Text] [Related]
33. TUC.338 promotes invasion and metastasis in colorectal cancer.
Wang C; Wang Z; Zhou J; Liu S; Wu C; Huang C; Ding Y
Int J Cancer; 2017 Mar; 140(6):1457-1464. PubMed ID: 27914101
[TBL] [Abstract][Full Text] [Related]
34. Expressions of matrix metalloproteinases in early-stage oral squamous cell carcinoma as predictive indicators for tumor metastases and prognosis.
Katayama A; Bandoh N; Kishibe K; Takahara M; Ogino T; Nonaka S; Harabuchi Y
Clin Cancer Res; 2004 Jan; 10(2):634-40. PubMed ID: 14760086
[TBL] [Abstract][Full Text] [Related]
35. [Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the hepatocellular carcinomas].
Wei QY; Wu YQ; Fan SQ
Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):212-6. PubMed ID: 14653069
[TBL] [Abstract][Full Text] [Related]
36. [Correlation between expression of MMP-2, MMP-9, TIMP-2, TIMP-1 and metastasis of neuroblastoma].
Cheng Y; Dong Q; Sun LR; Yang CM; Jiang BX
Zhonghua Zhong Liu Za Zhi; 2005 Mar; 27(3):164-6. PubMed ID: 15946567
[TBL] [Abstract][Full Text] [Related]
37. Expression of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of metalloproteinases 1 (TIMP-1) by colorectal cancer cells and adjacent stroma cells--associations with histopathology and patients outcome.
Jensen SA; Vainer B; Bartels A; Brünner N; Sørensen JB
Eur J Cancer; 2010 Dec; 46(18):3233-42. PubMed ID: 20801641
[TBL] [Abstract][Full Text] [Related]
38. Expression analysis and clinical significance of eIF4E, VEGF-C, E-cadherin and MMP-2 in colorectal adenocarcinoma.
Gao M; Zhang X; Li D; He P; Tian W; Zeng B
Oncotarget; 2016 Dec; 7(51):85502-85514. PubMed ID: 27907907
[TBL] [Abstract][Full Text] [Related]
39. Beneficial influence of microsatellite instability on gelatinase-tissue inhibitors of metalloproteinase balance in colorectal cancer.
Thiéfin G; Dupont A; Guillou PJ; Vitry F; Bouche O; Yaziji N; Lagarde S; Maquart FX; Palot JP; Hornebeck W; Diebold MD
Anticancer Res; 2007; 27(1B):583-8. PubMed ID: 17348445
[TBL] [Abstract][Full Text] [Related]
40. RUNX3 inhibits the metastasis and angiogenesis of colorectal cancer.
Kim BR; Kang MH; Kim JL; Na YJ; Park SH; Lee SI; Kang S; Joung SY; Lee SY; Lee DH; Min BW; Oh SC
Oncol Rep; 2016 Nov; 36(5):2601-2608. PubMed ID: 27633042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
